Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: The influence of partial realimentation

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Dostálová, Ivana ^a   Kaválková, Petra ^a   Papeová, Hana ^a   Domluvilová, Daniela ^a   Zikán, Vít ^a   Haluzík, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; LEPTIN;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL;

EID: 77951114307     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-34     Document Type: Article

References (48)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders Washington, DC: American Psychiatric Press 4 1994
2. Anorexia nervosa: definition, epidemiology, and cycle of risk. Bulik CM, Reba L, Siega-Riz AM, Reichborn-Kjennerud T, Int J Eat Disord 2005 37 2 S9 10.1002/eat.20107 15852310 (Pubitemid 40605013)
3. Neuroendocrine dysregulation of food intake in eating disorders. Monteleone P, Castaldo E, Maj M, Regul Pept 2008 149 39 50 10.1016/j.regpep. 2007.10.007 18582958
4. Biological correlates of binge eating. Yanovski SZ, Addict Behav 1995 20 705 712 10.1016/0306-4603(96)00092-5 8820523 (Pubitemid 26072993)
5. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. Nedvídková J, Krykorková I, Barták V, Papezová H, Gold PW, Alesci S, Pacak K, J Clin Endocrinol Metab 2003 88 1678 1682 10.1210/jc.2002-021669 12679456 (Pubitemid 36623387)
6. Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Dostálová I, Kopsk V, Dusková J, Papezová H, Pacák K, Nedvídková J, Regul Pept 2005 128 63 68 10.1016/j.regpep.2004.12.029 15721489 (Pubitemid 40255536)
7. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, Papezová H, Haluzik M, J Clin Endocrinol Metab 2005 90 1366 1370 10.1210/jc.2004-1364 15598689 (Pubitemid 40463989)
8. Leptin treatment in activity-based anorexia. Hillebrand JJ, Koeners MP, de Rijke CE, Kas MJ, Adan RA, Biol Psychiatry 2005 58 165 171 10.1016/j.biopsych.2005.03.011 16038687 (Pubitemid 41008134)
9. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction. Gorden P, Park JY, Arch Physiol Chem 2006 112 114 118 (Pubitemid 44384779)
10. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. Dostálová I, Kaválková P, Haluzíková D, Lacinová Z, Mráz M, Papezová H, Haluzík M, J Clin Endocrinol Metab 2008 93 3627 3632 10.1210/jc.2008-0746 18559909
11. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Dubuc GR, Phinney SD, Stern JS, Havel PJ, Metabolism 1998 47 429 434 10.1016/S0026-0495(98)90055-5 9550541 (Pubitemid 28180949)
12. Leptin production and action: relevance to energy balance in humans. Havel PJ, Am J Clin Nutr 1998 67 355 356 9497175
13. Integrative physiology of human adipose tissue. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW, Int J Obes Relat Metab Disord 2003 27 875 888 10.1038/sj.ijo.0802326 12861227 (Pubitemid 36918608)
14. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN, Proc Natl Acad Sci USA 1997 94 11514 11519 10.1073/pnas.94.21.11514 9326641 (Pubitemid 27451030)
15. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, Bing C, Endocrinology 2009 150 1688 1696 10.1210/en.2008-0952 19074584
16. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Böttner M, Suter-Crazzolara C, Schober A, Unsicker K, Cell Tissue Res 1999 297 103 110 10.1007/s004410051337 10398887 (Pubitemid 29313281)
17. Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. Schober A, Böttner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K, J Comp Neurol 2001 439 32 45 10.1002/cne.1333 11579380 (Pubitemid 32847019)
18. The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. Fairlie WD, Zhang HP, Wu WM, Pankhurst SL, Bauskin AR, Russell PK, Brown PK, Breit SN, J Biol Chem 2001 276 16911 16918 10.1074/jbc.M010000200 11278594
19. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML, Russell PK, Salamonsen LA, Wallace EM, Breit SN, J Clin Endocrinol Metab 2000 85 4781 4788 10.1210/jc.85.12.4781 11134143 (Pubitemid 32157666)
20. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN, Cancer Res 2005 65 2330 2336 10.1158/0008-5472.CAN-04-3827 15781647 (Pubitemid 40490143)
21. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, Weedon H, Milliken ST, Tak PP, Smith MD, Breit SN, Arthritis Rheum 2007 56 753 764 10.1002/art.22410 17328047 (Pubitemid 46399422)
22. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B, Breit SN, Clin Cancer Res 2003 9 2642 2650 12855642 (Pubitemid 36842108)
23. The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Wollmann W, Goodman ML, Bhat-Nakshatri P, Kishimoto H, Goulet RJ Jr, Mehrotra S, Morimiya A, Badve S, Nakshatri H, Carcinogenesis 2005 26 900 907 10.1093/carcin/bgi031 15677629 (Pubitemid 41214318)
24. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, Breit SN, Cancer Res 2006 66 4983 4986 10.1158/0008-5472.CAN-05-4067 16707416 (Pubitemid 43852864)
25. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Koopmann J, Rosenzweig CN, Zhang Z, Canto MI, Brown DA, Hunter M, Yeo C, Chan DW, Breit SN, Goggins M, Clin Cancer Res 2006 12 442 446 10.1158/1078-0432.CCR-05-0564 16428484 (Pubitemid 43166133)
26. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Wakchoure S, Swain TM, Hentunen TA, Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW, Selander KS, Prostate 2009 69 652 661 10.1002/pros.20913 19152406
27. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, Ridker PM, Lancet 2002 359 2159 2163 10.1016/S0140-6736(02)09093-1 12090982 (Pubitemid 34694024)
28. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL, Eur Heart J 2009 30 1057 1065 10.1093/eurheartj/ehn600 19168526
29. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG, Shock 2005 23 543 548 15897808 (Pubitemid 40677428)
30. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN, Nat Med 2007 13 1333 1340 10.1038/nm1677 17982462 (Pubitemid 350073601)
31. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M, J Clin Endocrinol Metab 2005 90 2920 2926 10.1210/jc.2004-1788 15713718 (Pubitemid 40686344)
32. Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE, Page CP, Peterson OL, Reinhardt GF, Williford WO, Am J Clin Nutr 1988 47 366 381 3124598 (Pubitemid 18061709)
33. The endocrinopathies of anorexia nervosa. Usdan LS, Khaodhiar L, Apovian CM, Endocr Pract 2008 14 1055 1063 19095609
34. Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalities. Jacoangeli F, Masala S, Staar Mezzasalma F, Fiori R, Martinetti A, Ficoneri C, Novi B, Pierangeli S, Marchetti G, Simonetti G, Bollea MR, Eat Weight Disord 2006 11 20 26 16801735
35. Bone density 11 years after anorexia nervosa onset in a controlled study of 39 cases. Wentz E, Mellström D, Gillberg C, Sundh V, Gillberg IC, Råstam M, Int J Eat Disord 2003 34 314 318 10.1002/eat.10192 12949922 (Pubitemid 37087705)
36. Correlates of low bone density in females with anorexia nervosa. Schneider M, Fisher M, Weinerman S, Lesser M, Int J Adolesc Med Health 2002 14 297 306 12617062 (Pubitemid 36192889)
37. Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Monteleone P, Martiadis V, Colurcio B, Maj M, Psychosom Med 2002 64 874 879 10.1097/01.PSY.0000024239.11538.A5 12461192 (Pubitemid 35417130)
38. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK, Eur J Clin Nutr 2003 57 1262 1267 10.1038/sj.ejcn.1601683 14506487 (Pubitemid 37259392)
39. Screening for osteoporosis in anorexia nervosa: prevalence and predictors of reduced bone mineral density. Winston AP, Alwazeer AE, Bankart MJ, Int J Eat Disord 2008 41 284 287 10.1002/eat.20501 18176948 (Pubitemid 351429789)
40. Predictors of osteopenia in premenopausal women with anorexia nervosa. Hay PJ, Delahunt JW, Hall A, Mitchell AW, Harper G, Salmond C, Calcif Tissue Int 1992 50 498 501 10.1007/BF00582161 1525703
41. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, Klibanski A, Miller KK, Bone 2008 43 135 139 10.1016/j.bone.2008.03.007 18486583
42. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Dostálová I, Roubícek T, Bá rtlová M, Mráz M, Lacinová Z, Haluzíková D, Kaválková P, Matoulek M, Kasalicky M, Haluzík M, Eur J Endocrinol 2009 161 397 404 10.1530/EJE-09-0417 19515791
43. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L, Catalano MG, Aragno M, Boccuzzi G, Oncol Rep 2007 18 1521 1527 17982639
44. Oxidative stress and metabolic syndrome. Roberts CK, Sindhu KK, Life Sci 2009 84 705 712 10.1016/j.lfs.2009.02.026 19281826
45. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Beattie JH, Wood AM, Newman AM, Bremner I, Choo KH, Michalska AE, Duncan JS, Trayhurn P, Proc Natl Acad Sci USA 1998 95 358 363 10.1073/pnas.95.1.358 9419380 (Pubitemid 28103958)
46. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M, Clin Endocrinol (Oxf) 2007 67 674 678 10.1111/j.1365-2265.2007.02944. x 17953628 (Pubitemid 47620431)
47. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Dolinková M, Dostálová I, Lacinová Z, Michalsk D, Haluzíková D, Mráz M, Kasalick M, Haluzík M, Mol Cell Endocrinol 2008 291 63 70 10.1016/j.mce.2008.05.001 18565643
48. Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG, J Surg Res 2006 130 45 51 10.1016/j.jss.2005.07.036 16154591 (Pubitemid 43028563)